Nanoencapsulated Doxorubicin Prevents Mucositis Development in Mice

Nanoencapsulated Doxorubicin Prevents Mucositis Development in Mice

Doxorubicin (DOX), a chemotherapy drug successfully used in the therapy of various types of cancer, is currently associated with the mucositis development, an inflammation that can cause ulcerative lesions in the mucosa of the gastrointestinal tract, abdominal pain and secondary infections. To incre...

Full description

Bibliographic Details
Main Authors: Cristiane M. Pinto, Laila S. Horta, Amanda P. Soares, Bárbara A. Carvalho, Enio Ferreira, Eduardo B. Lages, Lucas A. M. Ferreira, André A. G. Faraco, Helton C. Santiago, Gisele A. C. Goulart
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Pharmaceutics
Subjects:
nanostructured lipid carriers
doxorubicin
mucositis
Online Access:https://www.mdpi.com/1999-4923/13/7/1021

Similar Items

Similar Items